Lantern Pharma Inc. deeply regrets to announce the death of Dr. Franklyn Prendergast, a director of the Company. The Company learned on October 17, 2023 that Dr. Prendergast had died unexpectedly. Dr. Prendergast had served as a director of the Company since October 2019.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.19 USD | +1.64% | -3.58% | +44.63% |
05-09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.63% | 65.52M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- Lantern Pharma Inc. Announces the Death of Dr. Franklyn Prendergast, a Director of the Company